Femtosecond laser systems superior to microkeratome system

Article

Flap creation for bilateral LASIK is best performed using an IntraLase, VisuMax or Femto LDV, rather than a microkeratome.

An investigation featured in the Journal of Cataract and Refractive Surgery shows flap creation for bilateral LASIK is best performed using an IntraLase, VisuMax or Femto LDV, rather than a microkeratome.

A team led by Dr Hyunseok Ahn, Department of Ophthalmology, Institute of Vision and Research, Yonsei University College of Medicine, Seoul, South Korea, evaluated the thickness and side-cut angle of LASIK flaps made by 1 of 3 femtosecond lasers or an M2 microkeratome, using a RtVue Fourier–domain OCT.

The participants were split into 3 femtosecond laser groups and 1 microkeratome group. Femtosecond laser group 1 (Intralase) consisted of 50 eyes, group 2, 40 eyes (VisuMax), group 3, 64 eyes (Femto LDV) and the microkeratome group consisted of 52 eyes. Groups 1 and 2 had fairly even flap configuration. Group 3 and 4 had a meniscus shape, with group 3 having the greatest flap thickness predictability.

All three of the femtosecond laser systems performed better than the microkeratome system in general. The IntraLase's side-cut angle was closest to 90º and had the least difference between central flap thickness and the mean peripeheral. The femtosecond laser systems were also able to produce a variety of flap configurations depending on the each mechanism.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.